Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors

Xu, T; Sun, DJ; Chen, Y; Ouyang, L

Chen, Y; Ouyang, L (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.; Ouyang, L (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Peoples R China.; Chen, Y; Ouyang, L (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China.; Chen, Y (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610041, Peoples R China.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020; 199 ():

Abstract

mTOR (mammalian target of rapamycin), which is a serine/threonine kinase, has been well-established as being closely correlated with the occurrence of......

Full Text Link